Search patches Search patches
|
ExcitingAds! |
|||
1-800-Patches, Inc. is the premiere location for transdermal
products. Through nicotine patches, it has become the leading supplier of smoking
cessation products and services to consumers, corporations, and governments. With
its toll-free number, 1-800-PATCHES, and its website, 1800patches.com, it
markets, educates, integrates, simplifies, and delivers smoking cessation
products and services to consumers effectively and cost efficiently through its
proprietary administration and accountability system. 1-800-Patches offers
substantial discounts on all smoking cessation products and services produced by
major pharmaceutical manufacturers, including GlaxoSmithKline, Novartis,
Pharmacia, and Watson. It stocks a significant inventory of products from which
it can ship approximately 97% of its orders within one business day of receipt.
Gary Crocker
Founder, Chairman, & CEO
Mr. Crocker is currently President of Crocker Ventures, LLC (health care and
medical devices private investment firm) and Chairman of ARUP, Inc. (world
leading medical testing laboratory). He also serves on the Boards of the Western
Region of the Federal Reserve Bank, Interleuken Genetics, Inc. (genetic-based
diagnostics), Thermoform Technologies, Inc., (manufacturer of specialized plastic
packaging products), and the University of Utah. From 1985 - 1999 he was the
co-founding investor and served on the Board of TheraTech, Inc. (public
transdermal patch manufacturer) prior to its 1999 sale to Watson Pharmaceuticals
for $350 million. From 1983 - 1997, Mr. Crocker was President, CEO and founder of
Research Medical, Inc. (public medical device manufacturer), which was acquired
by Baxter International in 1997 for $236 million. Prior to Research Medical, Mr.
Crocker was vice President of Business Development and Director of Marketing for
Sorenson Research Company, a company Sole negotiator in sale of Sorenson division
to Abbott in 1980, for $118 million he helped sell to Abbott Laboratories in
1980. Mr. Crocker earned a Masters of Business Administration and also graduated
magna cum laude with a Bachelor of Science degree in Economics both from Harvard.
Dinesh C. Patel, Ph.D.
Founder & Director
Dr. Patel is currently Managing Director of vSpring Capital (early stage venture
capital fund). Dr. Patel is also the Founder, Chairman, President & CEO of Ashni
Naturaceuticals, Inc. (naturaceutical products) and Founder and Chairman of Salus
Therapeutics, Inc., (nucleic acid-based biotechnology). From 1985 - 1999, Dr.
Patel served as Co-founder, Chairman, President & CEO, of TheraTech, Inc. (public
transdermal patch manufacturer), a pioneer in the development and manufacture of
innovative drug delivery products. Under Dr. Patel's guidance, TheraTech
established strategic alliances with major pharmaceutical companies including Eli
Lilly, Pfizer, Proctor & Gamble, Roche, and SmithKline Beecham. Dr. Patel
directed the construction of a state-of-the-art manufacturing facility and
oversaw the company's R&D efforts through the manufacture of its currently
marketed transdermal products (leading products being transdermal testosterone
and estrogen hormone-replacement therapy patches). In January 1999, TheraTech was
purchased for $350 million by Watson Pharmaceuticals. Prior to founding TheraTech,
Dr. Patel served as senior scientist of drug delivery for Alcon Laboratories and
Research Pharmacist at Lederle Laboratories. Dr. Patel holds a doctorate in
physical pharmacy from the University of Michigan.
Roger Hendrix Jr.
Founder, Director, & Exec VP
Mr. Hendrix and Mr. Tanner recognized the need for a service-oriented,
technology-focused marketplace for the rapidly growing transdermal patch
industry?creating the 1-800-Patches concept. Mr. Hendrix was the East Coast
Regional Sales Manager of dotOne.com (now Critical Path (CPTH) where he won top
sales awards. Mr. Hendrix also serves on the Board of 1-800-Pharmacy, Inc.
(mail-order pharmacy). A former college basketball player, Mr. Hendrix received a
Bachelor of Science degree in Business Management, with an emphasis in
Entrepreneurship, from Brigham Young University.
Jonathan Tanner
Founder, Director, & Exec VP
Mr. Tanner and Mr. Hendrix recognized the need for a service-oriented,
technology-focused marketplace for the rapidly growing transdermal patch
industry?creating the 1-800-Patches concept. Mr. Tanner, was the Regional Manager
of Top Gun Promotions (direct sales) and Salesmen of the Year for Truly Nolen's
(pest control company) outsourced sales force. Mr. Tanner also serves on the
Board of 1-800-Pharmacy, Inc. (mail-order pharmacy). He graduated from Brigham
Young University with a Bachelor of Science in Business Management, with an
emphasis in Entrepreneurship and a minor in Filmmaking, having produced a PBS
documentary feature film and a National CINE Eagle award-winning film.
Dr. Ichiro Nakatomi
Director
Dr. Nakatomi is President, and CEO of NanoCarrier Co., Ltd. of Japan (nano-level
drug delivery), which he co-founded in 1999. Previously, Dr. Nakatomi was the
Vice President of Business Development for TheraTech, Inc. and concurrently
served as Representative Director of its Japanese branch. Prior to TheraTech, he
was responsible for the Pharmacology Laboratory, Research Planning, and Business
Development for Hisamitsu Pharmaceutical Co., Ltd. of Japan (drug delivery).